A Woman’s Heart: Improving Uptake and Awareness of Cardiovascular Screening for Middle-Aged Populations

References

• Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American heart association. Circulation. 2023;147(8):e93–e621. doi:10.1161/CIR.0000000000001123
   PubMed Web of Science ®Google Scholar
• Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361–2371. doi:10.1016/j.jacc.2022.11.005
   PubMed Web of Science ®Google Scholar
• Arora S, Stouffer GA, Kucharska-Newton AM, et al. Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation. 2019;139(8):1047–1056. doi:10.1161/CIRCULATIONAHA.118.037137
   PubMed Web of Science ®Google Scholar
• Curtin SC. Trends in cancer and heart disease death rates among adults aged 45–64: United States, 1999–2017. Natl Vital Stat Rep. 2019;68(5):1–9.
   PubMedGoogle Scholar
• Khan SU, Yedlapati SH, Lone AN, et al. A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999–2018. Eur Heart J Qual Care Clin Outcomes. 2022;8(3):315–323. doi:10.1093/ehjqcco/qcaa099
   PubMed Web of Science ®Google Scholar
• Abe T, Olanipekun T, Adedinsewo D, et al. Trends and outcomes of ST-segment-elevation myocardial infarction among young women in the United States. J Am Heart Assoc. 2023;12:e026811. doi:10.1161/JAHA.122.026811
   PubMed Web of Science ®Google Scholar
• Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021;397(10292):2385–2438. doi:10.1016/S0140-6736(21)00684-X
   PubMed Web of Science ®Google Scholar
• Timmis A, Vardas P, Townsend N, et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43(8):716–799. doi:10.1093/eurheartj/ehab892
   PubMed Web of Science ®Google Scholar
• Wenger NK. Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated. Circulation. 2012;126(5):604–611. doi:10.1161/CIRCULATIONAHA.111.086892
   PubMed Web of Science ®Google Scholar
• Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol. 2007;49(11):1230–1250. doi:10.1016/j.jacc.2007.02.020
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US). Committee on Women’s Health Research. Women’s Health Research: Progress, Pitfalls, and Promise; 2010.
   Google Scholar
• Cho L, Davis M, Elgendy I, et al. Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC State-of-The-Art Review. J Am Coll Cardiol. 2020;75(20):2602–2618. doi:10.1016/j.jacc.2020.03.060
   PubMed Web of Science ®Google Scholar
• Elder P, Sharma G, Gulati M, Michos ED. Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention. Am J Prev Cardiol. 2020;2:100028. doi:10.1016/j.ajpc.2020.100028
   PubMedGoogle Scholar
• O’Kelly AC, Michos ED, Shufelt CL, et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res. 2022;130(4):652–672. doi:10.1161/CIRCRESAHA.121.319895
   PubMed Web of Science ®Google Scholar
• Agarwala A, Michos ED, Samad Z, Ballantyne CM, Virani SS. The use of sex-specific factors in the assessment of women’s cardiovascular risk. Circulation. 2020;141(7):592–599. doi:10.1161/CIRCULATIONAHA.119.043429
   PubMed Web of Science ®Google Scholar
• Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2021;42(34):3227–3337. doi:10.1093/eurheartj/ehab484
   PubMed Web of Science ®Google Scholar
• Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596–e646. doi:10.1161/cir.0000000000000678
   PubMed Web of Science ®Google Scholar
• Pearson GJ, Thanassoulis G, Anderson TJ, et al. 2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults. Can J Cardiol. 2021;37(8):1129–1150. doi:10.1016/j.cjca.2021.03.016
   PubMed Web of Science ®Google Scholar
• Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: executive Summary: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1046–e1081. doi:10.1161/CIR.0000000000000624
   PubMed Web of Science ®Google Scholar
• Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–188. doi:10.1093/eurheartj/ehz455
   PubMed Web of Science ®Google Scholar
• Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49–73. doi:10.1161/01.cir.0000437741.48606.98
   PubMed Web of Science ®Google Scholar
• Amin NP, Martin SS, Blaha MJ, Nasir K, Blumenthal RS, Michos ED. Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines. J Am Coll Cardiol. 2014;63(25):2789–2794. doi:10.1016/j.jacc.2014.04.010
   PubMed Web of Science ®Google Scholar
• Group Sw, collaboration ESCCr. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439–2454. doi:10.1093/eurheartj/ehab309
   PubMed Web of Science ®Google Scholar
• Michos ED, Nasir K, Braunstein JB, et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis. 2006;184(1):201–206. doi:10.1016/j.atherosclerosis.2005.04.004
   PubMed Web of Science ®Google Scholar
• Michos ED, Vasamreddy CR, Becker DM, et al. Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. Am Heart J. 2005;150(6):1276–1281. doi:10.1016/j.ahj.2005.02.037
   PubMed Web of Science ®Google Scholar
• Aggarwal NR, Patel HN, Mehta LS, et al. Sex differences in ischemic heart disease: advances, obstacles, and next steps. Circ Cardiovasc Qual Outcomes. 2018;11(2):e004437. doi:10.1161/CIRCOUTCOMES.117.004437
   PubMed Web of Science ®Google Scholar
• Broni EK, Ndumele CE, Echouffo-Tcheugui JB, Kalyani RR, Bennett WL, Michos ED. The diabetes-cardiovascular connection in women: understanding the known risks, outcomes, and implications for care. Curr Diab Rep. 2022;22(1):11–25. doi:10.1007/s11892-021-01444-x
   PubMed Web of Science ®Google Scholar
• Angoulvant D, Ducluzeau PH, Renoult-Pierre P, et al. Impact of gender on relative rates of cardiovascular events in patients with diabetes. Diabetes Metab. 2021;47(5):101226. doi:10.1016/j.diabet.2021.101226
   PubMed Web of Science ®Google Scholar
• Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57(8):1542–1551. doi:10.1007/s00125-014-3260-6
   PubMed Web of Science ®Google Scholar
• Prospective Studies C, Asia Pacific Cohort Studies C, Halsey J. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies. Lancet Diabetes Endocrinol. 2018;6(7):538–546. doi:10.1016/S2213-8587(18)30079-2
   PubMed Web of Science ®Google Scholar
• Al-Salameh A, Chanson P, Bucher S, Ringa V, Becquemont L. Cardiovascular disease in type 2 diabetes: a review of sex-related differences in predisposition and prevention. Mayo Clin Proceed. 2019;94(2):287–308. doi:10.1016/j.mayocp.2018.08.007
   PubMed Web of Science ®Google Scholar
• Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162(16):1867–1872. doi:10.1001/archinte.162.16.1867
   PubMedGoogle Scholar
• Pasquali R, Casimirri F, Labate AM, et al. Body weight, fat distribution and the menopausal status in women. The VMH Collaborative Group. Int J Obes Relat Metab Disord. 1994;18(9):614–621.
   PubMed Web of Science ®Google Scholar
• Kulie T, Slattengren A, Redmer J, Counts H, Eglash A, Schrager S. Obesity and women’s health: an evidence-based review. J Am Board Fam Med. 2011;24(1):75–85. doi:10.3122/jabfm.2011.01.100076
   PubMed Web of Science ®Google Scholar
• Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011;378(9799):1297–1305. doi:10.1016/S0140-6736(11)60781-2
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA. 2005;294(4):466–472. doi:10.1001/jama.294.4.466
   PubMed Web of Science ®Google Scholar
• Kovell LC, Harrington CM, Michos ED. Update on blood pressure control among US adults with hypertension. JAMA. 2021;325(6):586–587. doi:10.1001/jama.2020.23982
   PubMed Web of Science ®Google Scholar
• Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll of Cardiol. 2009;54(25):2366–2373. doi:10.1016/j.jacc.2009.10.009
   PubMed Web of Science ®Google Scholar
• Lau ES, Michos ED. Blood pressure trajectories through the menopause transition: different paths, same journey. Circ Res. 2022;130(3):323–325. doi:10.1161/CIRCRESAHA.122.320664
   PubMed Web of Science ®Google Scholar
• Full KM, Huang T, Shah NA, et al. Sleep irregularity and subclinical markers of cardiovascular disease: the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2023;12(4):e027361. doi:10.1161/JAHA.122.027361
   PubMed Web of Science ®Google Scholar
• Daugherty SL, Carter JR, Bourjeily G. Cardiovascular disease in women across the lifespan: the importance of sleep. J Womens Health. 2020;29(3):452–460. doi:10.1089/jwh.2020.8331
   Web of Science ®Google Scholar
• Dean YE, Shebl MA, Rouzan SS, et al. Association between insomnia and the incidence of myocardial infarction: a systematic review and meta-analysis. Clin Cardiol. 2023;46:376–385. doi:10.1002/clc.23984
   PubMed Web of Science ®Google Scholar
• Kadier K, Qin L, Ainiwaer A, et al. Association of sleep-related disorders with cardiovascular disease among adults in the United States: a cross-sectional study based on national health and nutrition examination survey 2005–2008. Front Cardiovasc Med. 2022;9:954238. doi:10.3389/fcvm.2022.954238
   PubMedGoogle Scholar
• Martinez GM. Trends and Patterns in Menarche in the United States: 1995 through 2013–2017. Natl Health Stat Report. 2020;146:1–12.
   Google Scholar
• Peters SA, Woodward M. Women’s reproductive factors and incident cardiovascular disease in the UK Biobank. Heart. 2018;104(13):1069–1075. doi:10.1136/heartjnl-2017-312289
   PubMed Web of Science ®Google Scholar
• Canoy D, Beral V, Balkwill A, et al. Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort. Circulation. 2015;131(3):237–244. doi:10.1161/CIRCULATIONAHA.114.010070
   PubMed Web of Science ®Google Scholar
• Lee JJ, Cook-Wiens G, Johnson BD, et al. Age at menarche and risk of cardiovascular disease outcomes: findings from the national heart lung and blood institute-sponsored women’s Ischemia syndrome evaluation. J Am Heart Assoc. 2019;8(12):e012406. doi:10.1161/jaha.119.012406
   PubMed Web of Science ®Google Scholar
• Guan C, Zahid S, Minhas AS, et al. Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease. Fertil Steril. 2022;117(5):924–935. doi:10.1016/j.fertnstert.2022.03.009
   PubMed Web of Science ®Google Scholar
• Osibogun O, Ogunmoroti O, Michos ED. Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention. Trends Cardiovasc Med. 2020;30(7):399–404. doi:10.1016/j.tcm.2019.08.010
   PubMed Web of Science ®Google Scholar
• Osibogun O, Ogunmoroti O, Kolade OB, et al. A systematic review and meta-analysis of the association between polycystic ovary syndrome and coronary artery calcification. J Womens Health. 2022;31(6):762–771. doi:10.1089/jwh.2021.0608
   Web of Science ®Google Scholar
• Okoth K, Chandan JS, Marshall T, et al. Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review. BMJ. 2020;371:m3502. doi:10.1136/bmj.m3502
   PubMed Web of Science ®Google Scholar
• Oliver-Williams C, Vassard D, Pinborg A, Schmidt L. Risk of cardiovascular disease for women with polycystic ovary syndrome: results from a national Danish registry cohort study. Eur J Prev Cardiol. 2020;2047487320939674. doi:10.1177/2047487320939674
   Web of Science ®Google Scholar
• Wang YX, Arvizu M, Rich-Edwards JW, et al. Menstrual cycle regularity and length across the reproductive lifespan and risk of premature mortality: prospective cohort study. BMJ. 2020;371:m3464. doi:10.1136/bmj.m3464
   PubMedGoogle Scholar
• Solomon CG, Hu FB, Dunaif A, et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab. 2002;87(5):2013–2017. doi:10.1210/jcem.87.5.8471
   PubMed Web of Science ®Google Scholar
• Wang YX, Stuart JJ, Rich-Edwards JW, et al. Menstrual cycle regularity and length across the reproductive lifespan and risk of cardiovascular disease. JAMA Netw Open. 2022;5(10):e2238513. doi:10.1001/jamanetworkopen.2022.38513
   PubMed Web of Science ®Google Scholar
• Lawlor DA, Emberson JR, Ebrahim S, et al. Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British women’s heart and health study and the British regional heart study. Circulation. 2003;107(9):1260–1264. doi:10.1161/01.cir.0000053441.43495.1a
   PubMed Web of Science ®Google Scholar
• Peters SA, van der Schouw YT, Wood AM, et al. Parity, breastfeeding and risk of coronary heart disease: a pan-European case-cohort study. Eur J Prev Cardiol. 2016;23(16):1755–1765. doi:10.1177/2047487316658571
   PubMed Web of Science ®Google Scholar
• Li W, Ruan W, Lu Z, Wang D. Parity and risk of maternal cardiovascular disease: a dose-response meta-analysis of cohort studies. Eur J Prev Cardiol. 2019;26(6):592–602. doi:10.1177/2047487318818265
   PubMed Web of Science ®Google Scholar
• Parikh NI, Cnattingius S, Dickman PW, Mittleman MA, Ludvigsson JF, Ingelsson E. Parity and risk of later-life maternal cardiovascular disease. Am Heart J. 2010;159(2):215–221 e6. doi:10.1016/j.ahj.2009.11.017
   PubMed Web of Science ®Google Scholar
• Kazzi B, Ogunmoroti O, Rodriguez CP, et al. Parity history and later life sex hormone levels in the multi-ethnic study of atherosclerosis (Mesa). Can J Cardiol. 2022;38(12):1893–1900. doi:10.1016/j.cjca.2022.09.004
   PubMedGoogle Scholar
• Rodriguez CP, Ogunmoroti O, Quispe R, et al. The association between multiparity and adipokine levels: the multi-ethnic study of atherosclerosis. J Womens Health. 2022;31(5):741–749. doi:10.1089/jwh.2021.0091
   Web of Science ®Google Scholar
• Ogunmoroti O, Osibogun O, Kolade OB, et al. Multiparity is associated with poorer cardiovascular health among women from the Multi-Ethnic Study of Atherosclerosis. Am J Obstet Gynecol. 2019;221(6):631 e1–631 e16. doi:10.1016/j.ajog.2019.07.001
   PubMed Web of Science ®Google Scholar
• Hauspurg A, Ying W, Hubel CA, Michos ED, Ouyang P. Adverse pregnancy outcomes and future maternal cardiovascular disease. Clin Cardiol. 2018;41(2):239–246. doi:10.1002/clc.22887
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974. doi:10.1136/bmj.39335.385301.BE
   PubMed Web of Science ®Google Scholar
• Wu P, Haththotuwa R, Kwok CS, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2). doi:10.1161/CIRCOUTCOMES.116.003497
   PubMed Web of Science ®Google Scholar
• Parikh NI, Gonzalez JM, Anderson CAM, et al. Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American heart association. Circulation. 2021;143(18):e902–e916. doi:10.1161/CIR.0000000000000961
   PubMed Web of Science ®Google Scholar
• Wu P, Gulati M, Kwok CS, et al. Preterm delivery and future risk of maternal cardiovascular disease: a systematic review and meta-analysis. J Am Heart Assoc. 2018;7(2). doi:10.1161/JAHA.117.007809
   Web of Science ®Google Scholar
• Bonamy AK, Parikh NI, Cnattingius S, Ludvigsson JF, Ingelsson E. Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. Circulation. 2011;124(25):2839–2846. doi:10.1161/CIRCULATIONAHA.111.034884
   PubMed Web of Science ®Google Scholar
• Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019;62(6):905–914. doi:10.1007/s00125-019-4840-2
   PubMed Web of Science ®Google Scholar
• Gunderson EP, Sun B, Catov JM, et al. Gestational diabetes history and glucose tolerance after pregnancy associated with coronary artery calcium in women during midlife: the CARDIA study. Circulation. 2021;143(10):974–987. doi:10.1161/CIRCULATIONAHA.120.047320
   PubMed Web of Science ®Google Scholar
• Murugappan G, Leonard SA, Farland LV, et al. Association of infertility with atherosclerotic cardiovascular disease among postmenopausal participants in the women’s health initiative. Fertil Steril. 2022;117(5):1038–1046. doi:10.1016/j.fertnstert.2022.02.005
   PubMed Web of Science ®Google Scholar
• Lau ES, Wang D, Roberts M, et al. Infertility and risk of heart failure in the women’s health initiative. J Am Coll Cardiol. 2022;79(16):1594–1603. doi:10.1016/j.jacc.2022.02.020
   PubMed Web of Science ®Google Scholar
• Wang YX, Minguez-Alarcon L, Gaskins AJ, et al. Pregnancy loss and risk of cardiovascular disease: the Nurses’ Health Study II. Eur Heart J. 2022;43(3):190–199. doi:10.1093/eurheartj/ehab737
   PubMed Web of Science ®Google Scholar
• Gunderson EP, Lewis CE, Lin Y, et al. Lactation duration and progression to diabetes in women across the childbearing years: the 30-Year CARDIA study. JAMA Intern Med. 2018;178(3):328–337. doi:10.1001/jamainternmed.2017.7978
   PubMed Web of Science ®Google Scholar
• Tschiderer L, Seekircher L, Kunutsor SK, Peters SAE, O’Keeffe LM, Willeit P. Breastfeeding is associated with a reduced maternal cardiovascular risk: systematic review and meta-analysis involving data from 8 studies and 1 192 700 Parous women. J Am Heart Assoc. 2022;11(2):e022746. doi:10.1161/JAHA.121.022746
   PubMed Web of Science ®Google Scholar
• Magnus MC, Wallace MK, Demirci JR, Catov JM, Schmella MJ, Fraser A. Breastfeeding and later-life cardiometabolic health in women with and without hypertensive disorders of pregnancy. J Am Heart Assoc. 2023;e026696. doi:10.1161/JAHA.122.026696
   PubMed Web of Science ®Google Scholar
• Budeiri DJ, Li Wan Po A, Dornan JC. Clinical trials of treatments of premenstrual syndrome: entry criteria and scales for measuring treatment outcomes. Br J Obstet Gynaecol. 1994;101(8):689–695. doi:10.1111/j.1471-0528.1994.tb13186.x
   PubMedGoogle Scholar
• Stamatelopoulos KS, Georgiopoulos G, Papaioannou T, et al. Can premenstrual syndrome affect arterial stiffness or blood pressure? Atherosclerosis. 2012;224(1):170–176. doi:10.1016/j.atherosclerosis.2012.05.037
   PubMed Web of Science ®Google Scholar
• Bertone-Johnson ER, Whitcomb BW, Rich-Edwards JW, Hankinson SE, Manson JE. Premenstrual syndrome and subsequent risk of hypertension in a prospective study. Am J Epidemiol. 2015;182(12):1000–1009. doi:10.1093/aje/kwv159
   PubMed Web of Science ®Google Scholar
• Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85(4):447–452. doi:10.7326/0003-4819-85-4-447
   PubMed Web of Science ®Google Scholar
• Honigberg MC, Zekavat SM, Aragam K, et al. Association of premature natural and surgical menopause with incident cardiovascular disease. JAMA. 2019;322(24):2411–2421. doi:10.1001/jama.2019.19191
   PubMed Web of Science ®Google Scholar
• Chu JH, Michos ED, Ouyang P, et al. Coronary artery calcium and atherosclerotic cardiovascular disease risk in women with early menopause: the multi-ethnic study of atherosclerosis (Mesa). Am J Prev Cardiol. 2022;11:100362. doi:10.1016/j.ajpc.2022.100362
   PubMedGoogle Scholar
• Yang L, Lin L, Kartsonaki C, et al. Menopause characteristics, total reproductive years, and risk of cardiovascular disease among Chinese women. Circ Cardiovasc Qual Outcomes. 2017;10(11):e004235. doi:10.1161/CIRCOUTCOMES.117.004235
   PubMed Web of Science ®Google Scholar
• Mishra SR, Chung HF, Waller M, Mishra GD. Duration of estrogen exposure during reproductive years, age at menarche and age at menopause, and risk of cardiovascular disease events, all-cause and cardiovascular mortality: a systematic review and meta-analysis. BJOG. 2021;128(5):809–821. doi:10.1111/1471-0528.16524
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Bitzer J, Cano A, et al. Menopause symptom management in women with dyslipidemias: an EMAS clinical guide. Maturitas. 2020;135:82–88. doi:10.1016/j.maturitas.2020.03.007
   PubMed Web of Science ®Google Scholar
• Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas. 1990;12(4):321–331. doi:10.1016/0378-5122(90)90012-u
   PubMed Web of Science ®Google Scholar
• Nudy M, Aragaki AK, Jiang X, et al. The severity of individual menopausal symptoms, cardiovascular disease, and all-cause mortality in the women’s health initiative observational cohort. Menopause. 2022;29(12):1365–1374. doi:10.1097/GME.0000000000002089
   PubMedGoogle Scholar
• Thurston RC, Aslanidou Vlachos HE, Derby CA, et al. Menopausal vasomotor symptoms and risk of incident cardiovascular disease events in SWAN. J Am Heart Assoc. 2021;10(3):e017416. doi:10.1161/JAHA.120.017416
   PubMed Web of Science ®Google Scholar
• Zeller CB, Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev. 2008;4(2):116–122. doi:10.2174/157340308784245775
   PubMedGoogle Scholar
• Avina-Zubieta JA, To F, Vostretsova K, De Vera M, Sayre EC, Esdaile JM. Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population-based study. Arthritis Care Res. 2017;69(6):849–856. doi:10.1002/acr.23018
   PubMed Web of Science ®Google Scholar
• Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349(25):2407–2415. doi:10.1056/NEJMoa035611
   PubMed Web of Science ®Google Scholar
• Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59(12):1690–1697. doi:10.1002/art.24092
   PubMed Web of Science ®Google Scholar
• Myasoedova E, Chandran A, Ilhan B, et al. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease. Ann Rheum Dis. 2016;75(3):560–565. doi:10.1136/annrheumdis-2014-206411
   PubMed Web of Science ®Google Scholar
• Agca R, Heslinga SC, Rollefstad S, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76(1):17–28. doi:10.1136/annrheumdis-2016-209775
   PubMed Web of Science ®Google Scholar
• Quispe R, Varghese B, Michos ED. Inflammatory Diseases and Risk of Atherosclerotic Cardiovascular Disease: a New Focus on Prevention. In: Shapiro MD, editor. Cardiovascular Risk Assessment in Primary Prevention. Springer International Publishing; 2022:247–270.
   Google Scholar
• Mannoh I, Hussien M, Commodore-Mensah Y, Michos ED. Impact of social determinants of health on cardiovascular disease prevention. Curr Opin Cardiol. 2021;36(5):572–579. doi:10.1097/HCO.0000000000000893
   PubMed Web of Science ®Google Scholar
• Lindley KJ, Aggarwal NR, Briller JE, et al. Socioeconomic determinants of health and cardiovascular outcomes in women: JACC review topic of the week. J Am Coll Cardiol. 2021;78(19):1919–1929. doi:10.1016/j.jacc.2021.09.011
   PubMed Web of Science ®Google Scholar
• Churchwell K, Elkind MSV, Benjamin RM, et al. Call to action: structural racism as a fundamental driver of health disparities: a presidential advisory From the American Heart Association. Circulation. 2020;142(24):e454–e468. doi:10.1161/CIR.0000000000000936
   PubMed Web of Science ®Google Scholar
• Caceres BA, Streed CG Jr, Corliss HL, et al. Assessing and addressing cardiovascular health in LGBTQ adults: a scientific statement from the American Heart Association. Circulation. 2020;142(19):e321–e332. doi:10.1161/CIR.0000000000000914
   PubMed Web of Science ®Google Scholar
• Michos ED, Blaha MJ, Blumenthal RS. Use of the coronary artery calcium score in discussion of initiation of statin therapy in primary prevention. Mayo Clinic Proceed. 2017;92(12):1831–1841. doi:10.1016/j.mayocp.2017.10.001
   PubMed Web of Science ®Google Scholar
• Shaw LJ, Min JK, Nasir K, et al. Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium. Eur Heart J. 2018;39(41):3727–3735. doi:10.1093/eurheartj/ehy534
   PubMed Web of Science ®Google Scholar
• Wong ND, Cordola Hsu AR, Rozanski A, et al. Sex differences in coronary artery calcium and mortality from coronary heart disease, cardiovascular disease, and all causes in adults with diabetes: the coronary calcium consortium. Diabetes Care. 2020;43(10):2597–2606. doi:10.2337/dc20-0166
   PubMed Web of Science ®Google Scholar
• Blaha MJ, Abdelhamid M, Santilli F, Shi Z, Sibbing D. Advanced subclinical atherosclerosis: a novel category within the cardiovascular risk continuum with distinct treatment implications. Am J Prev Cardiol. 2023;13:100456. doi:10.1016/j.ajpc.2022.100456
   PubMedGoogle Scholar
• Budoff MJ, Young R, Burke G, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (Mesa). Eur Heart J. 2018;39(25):2401–2408. doi:10.1093/eurheartj/ehy217
   PubMed Web of Science ®Google Scholar
• Blaha MJ, Cainzos-Achirica M, Greenland P, et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the multi-ethnic study of atherosclerosis (Mesa). Circulation. 2016;133(9):849–858. doi:10.1161/CIRCULATIONAHA.115.018524
   PubMed Web of Science ®Google Scholar
• Patel KK, Peri-Okonny PA, Qarajeh R, et al. Prognostic relationship between coronary artery calcium score, perfusion defects, and myocardial blood flow reserve in patients with suspected coronary artery disease. Circ Cardiovasc Imaging. 2022;15(4):e012599. doi:10.1161/CIRCIMAGING.121.012599
   PubMed Web of Science ®Google Scholar
• Mortensen MB, Gaur S, Frimmer A, et al. Association of age with the diagnostic value of coronary artery calcium score for ruling out coronary stenosis in symptomatic patients. JAMA Cardiol. 2022;7(1):36–44. doi:10.1001/jamacardio.2021.4406
   PubMed Web of Science ®Google Scholar
• Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: executive Summary: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22):e368–e454. doi:10.1161/CIR.0000000000001030
   Web of Science ®Google Scholar
• Bullock-Palmer RP, Michos ED, Gaballa D, Blankstein R. The role of imaging in preventive cardiology in women. Curr Cardiol Rep. 2023;25(2):29–40. doi:10.1007/s11886-022-01828-9
   PubMed Web of Science ®Google Scholar
• Investigators S-H, Newby DE, Adamson PD, et al. Coronary CT Angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018;379(10):924–933. doi:10.1056/NEJMoa1805971
   PubMed Web of Science ®Google Scholar
• Leipsic J, Taylor CM, Gransar H, et al. Sex-based prognostic implications of nonobstructive coronary artery disease: results from the international multicenter CONFIRM study. Radiology. 2014;273(2):393–400. doi:10.1148/radiol.14140269
   PubMed Web of Science ®Google Scholar
• Ferencik M, Mayrhofer T, Bittner DO, et al. Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial. JAMA Cardiol. 2018;3(2):144–152. doi:10.1001/jamacardio.2017.4973
   PubMed Web of Science ®Google Scholar
• Reynolds HR, Bairey Merz CN, Berry C, et al. Coronary arterial function and disease in women with no obstructive coronary arteries. Circ Res. 2022;130(4):529–551. doi:10.1161/CIRCRESAHA.121.319892
   PubMed Web of Science ®Google Scholar
• Bairey Merz CN, Shaw LJ, Reis SE, et al. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3 Suppl):S21–9. doi:10.1016/j.jacc.2004.12.084
   PubMed Web of Science ®Google Scholar
• Reynolds HR, Picard MH, Spertus JA, et al. Natural history of patients with ischemia and no obstructive coronary artery disease: the CIAO-ISCHEMIA Study. Circulation. 2021;144(13):1008–1023. doi:10.1161/CIRCULATIONAHA.120.046791
   PubMed Web of Science ®Google Scholar
• Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22):e368–e454. doi:10.1161/CIR.0000000000001029
   Web of Science ®Google Scholar
• Ford TJ, Corcoran D, Berry C. Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need. Heart. 2018;104(4):284–292. doi:10.1136/heartjnl-2017-311446
   PubMed Web of Science ®Google Scholar
• AlBadri A, Bairey Merz CN, Johnson BD, et al. Impact of abnormal coronary reactivity on long-term clinical outcomes in women. J Am Coll Cardiol. 2019;73(6):684–693. doi:10.1016/j.jacc.2018.11.040
   PubMed Web of Science ®Google Scholar
• Taqueti VR, Shaw LJ, Cook NR, et al. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation. 2017;135(6):566–577. doi:10.1161/CIRCULATIONAHA.116.023266
   PubMed Web of Science ®Google Scholar
• Ford TJ, Stanley B, Sidik N, et al. 1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA). JACC Cardiovasc Interv. 2020;13(1):33–45. doi:10.1016/j.jcin.2019.11.001
   PubMed Web of Science ®Google Scholar
• Reynolds HR, Maehara A, Kwong RY, et al. Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women. Circulation. 2021;143(7):624–640. doi:10.1161/CIRCULATIONAHA.120.052008
   PubMed Web of Science ®Google Scholar
• Minissian MB, Mehta PK, Hayes SN, et al. Ischemic heart disease in young women: JACC review topic of the week. J Am Coll Cardiol. 2022;80(10):1014–1022. doi:10.1016/j.jacc.2022.01.057
   PubMed Web of Science ®Google Scholar
• Daneshrad JA, Ordovas K, Sierra-Galan LM, et al. Role of cardiac magnetic resonance imaging in the evaluation of MINOCA. J Clin Med. 2023;12(5):2017. doi:10.3390/jcm12052017
   PubMed Web of Science ®Google Scholar
• Khan MS, Shahid I, Siddiqi TJ, et al. Ten-year trends in enrollment of women and minorities in pivotal trials supporting recent US food and drug administration approval of novel cardiometabolic drugs. J Am Heart Assoc. 2020;9(11):e015594. doi:10.1161/JAHA.119.015594
   PubMed Web of Science ®Google Scholar
• Khan SU, Khan MZ, Raghu Subramanian C, et al. Participation of women and older participants in randomized clinical trials of lipid-lowering therapies: a systematic review. JAMA Netw Open. 2020;3(5):e205202. doi:10.1001/jamanetworkopen.2020.5202
   PubMed Web of Science ®Google Scholar
• Khan SU, Michos ED. Women in stroke trials-A tale of perpetual inequity in cardiovascular research. JAMA Neurol. 2021;78(6):654–656. doi:10.1001/jamaneurol.2021.0624
   PubMed Web of Science ®Google Scholar
• Michos ED, Reddy TK, Gulati M, et al. Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: an ASPC practice statement. Am J Prev Cardiol. 2021;8:100250. doi:10.1016/j.ajpc.2021.100250
   PubMedGoogle Scholar
• Thakkar A, Agarwala A, Michos ED. Secondary prevention of cardiovascular disease in women: closing the gap. Eur Cardiol. 2021;16:e41. doi:10.15420/ecr.2021.24
   PubMed Web of Science ®Google Scholar
• Delamater L, Santoro N. Management of the Perimenopause. Clin Obstet Gynecol. 2018;61(3):419–432. doi:10.1097/GRF.0000000000000389
   PubMed Web of Science ®Google Scholar
• Bacon JL. The menopausal transition. Obstet Gynecol Clin North Am. 2017;44(2):285–296. doi:10.1016/j.ogc.2017.02.008
   PubMed Web of Science ®Google Scholar
• Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res. 2002;57:257–275. doi:10.1210/rp.57.1.257
   PubMedGoogle Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–333. doi:10.1001/jama.288.3.321
   PubMed Web of Science ®Google Scholar
• Chester RC, Kling JM, Manson JE. What the Women’s Health Initiative has taught us about menopausal hormone therapy. Clin Cardiol. 2018;41(2):247–252. doi:10.1002/clc.22891
   PubMed Web of Science ®Google Scholar
• Lundberg G, Wu P, Wenger N. Menopausal hormone therapy: a comprehensive review. Curr Atheroscler Rep. 2020;22(8):33. doi:10.1007/s11883-020-00854-8
   PubMed Web of Science ®Google Scholar